Albireo Pharma Inc (ALBO) stock has risen 50.07% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ALBO stock a score of 73 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 96. ALBO's rank also includes a fundamental score of 92. In addition to the average rating from Wall Street analysts, ALBO stock has a mean target price of 69.857. This means analysts expect the stock to climb 106.25% over the next 12 months. The short-term technical score for ALBO is 32.
What's Happening with ALBO Stock Today
Albireo Pharma Inc (ALBO) stock has risen 4.09% while the S&P 500 has risen 0.14% as of 10:38 AM on Friday, Sep 25. ALBO has risen $1.33 from the previous closing price of $32.54 on volume of 64,246 shares. Over the past year the S&P 500 is up 9.19% while ALBO has risen 50.07%. ALBO lost -$5.92 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Albireo Pharma Inc (ALBO) Stock.